Winter Park, Florida--(Newsfile Corp. - July 15, 2026) - Adia Med Inc. (OTCQB: ADIA), a clinical-stage regenerative medicine company, today announced the launch of its redesigned corporate website. The redesigned website is now live, with the project still in progress and active changes and improvements currently being made.Adia Med Inc. (Formerly Adia Nutrition Inc.) Launches Redesigned Corporate WebsiteTo view an enhanced version of this graphic, please...

Winter Park, Florida--(Newsfile Corp. - July 9, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA) announced today that FINRA has processed its corporate name change to Adia Med Inc. on an expedited timeline. The name change will be reflected on the FINRA Daily List today, with trading under the new name expected to begin tomorrow, Friday, July 10, 2026, on the OTC Markets.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10520/304434_adiamedlogo.jpgThe...

Winter Park, Florida--(Newsfile Corp. - July 7, 2026) - Adia Nutrition Inc. (OTCQB: ADIA) today announced it has entered the final stage of its corporate name change application from Adia Nutrition Inc. to Adia Med Inc. After several months of review by the Financial Industry Regulatory Authority (FINRA), including three rounds of comments and the submission of detailed supporting documentation, the Company believes it has now met all outstanding requirements. FINRA approval is anticipated...

Winter Park, Florida--(Newsfile Corp. - June 10, 2026) - Adia Nutrition Inc. (OTCQB: ADIA) is pleased to confirm that the State of Nevada has officially approved the company's name change to Adia Med Inc.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10520/300817_screenshot_adia_med_inc_official_on_nevada.jpgThe move is more than cosmetic — it's a clear signal of where Adia is headed. Shifting from "Nutrition" to "Med" puts the spotlight on the...

Winter Park, Florida--(Newsfile Corp. - May 5, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA), a publicly traded company based in Winter Park, Florida, dedicated to advancing regenerative therapies for chronic diseases, today announced that its pivotal clinical study on kidney disease has received Institutional Review Board (IRB) approval and has been successfully submitted to ClinicalTrials.gov.Adia Nutrition Announces IRB Approval and ClinicalTrials.gov Submission for Groundbreaking Stem Cell...

Winter Park, Florida--(Newsfile Corp. - April 28, 2026) - Adia Nutrition, (OTCQB: ADIA) a leader in advanced regenerative health solutions, today announced a major milestone in its clinical research pipeline.Adia Nutrition Announces Three Pivotal Clinical Studies Receive Major IRB Milestone - Final Approval Now Clearly in SightTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10520/294388_adiaimage.jpgThe company has successfully received the second...

Winter Park, Florida--(Newsfile Corp. - April 15, 2026) -  Adia Nutrition, Inc. (OTCQB: ADIA), a publicly traded company focused on regenerative medicine, stem cell therapies, and biologic products, today announced that it is in the process of changing its corporate name to Adia Med, Inc.The name change reflects the company's evolving business model, which has shifted significantly toward advanced medical treatments and biologics. Adia now operates through key divisions including Adia Med...

Winter Park, Florida--(Newsfile Corp. - March 24, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine through its Adia Med division, is excited to announce a special virtual Zoom presentation happening tonight, Tuesday, March 24, 2026, at 6:00 PM EDT, with the Center for Autism and Related Disabilities (CARD) at the University of Central Florida (UCF).This high-impact session will deliver critical information directly to families, caregivers, and professionals about Adia...

Orlando, Florida--(Newsfile Corp. - March 9, 2026) - Adia Nutrition's (OTCQB: ADIA) subsidiary, Adia Med, has launched a complete digital refresh of its online presence. Through a strategic partnership with ZenChange Marketing, Adia Med has relaunched its website with a modern, streamlined design focused on transparency, accessibility, and clear information about its investigational studies. The update makes it easier for families, researchers, and healthcare professionals to explore the...

Winter Park, Florida--(Newsfile Corp. - March 3, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a company focused on regenerative medicine and therapeutic solutions, today announced that its subsidiary, Adia Med of Winter Park, LLC, has submitted its final revised protocol to the Institutional Review Board (IRB) for the lower back pain clinical study.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10520/286105_img_8679_1.jpgFollowing the initial...

BOSTON, Feb. 20, 2026 – Biotechnology firm Sōlaria Biō has released new clinical evidence demonstrating that the microbial composition in its synbiotic medical food, Bōndia™, is effectively delivered to the human gut and performs as intended, reinforcing its role in improving bone health. The findings, published in the peer-reviewed journal Beneficial Microbes, detailed the results …

Winter Park, Florida--(Newsfile Corp. - February 16, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and innovative therapeutic solutions, today announced that its subsidiary, Adia Med of Winter Park, LLC, has submitted its second clinical study for Institutional Review Board (IRB) review. This pivotal study will evaluate the efficacy of AdiaVita, Adia Med's proprietary umbilical cord blood-derived stem cell and exosome product, in alleviating lower back pain through...